Cargando…
Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS)
Domestic dogs share the same environment as humans, and they represent a valuable animal model to study naturally-occurring human disease. Platelet proteomics holds promise for the discovery of biomarkers that capture the contribution of platelets to the pathophysiology of many disease states, howev...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853320/ https://www.ncbi.nlm.nih.gov/pubmed/31721811 http://dx.doi.org/10.1371/journal.pone.0224891 |
_version_ | 1783470024418131968 |
---|---|
author | Cremer, Signe E. Catalfamo, James L. Goggs, Robert Seemann, Stefan E. Kristensen, Annemarie T. Brooks, Marjory B. |
author_facet | Cremer, Signe E. Catalfamo, James L. Goggs, Robert Seemann, Stefan E. Kristensen, Annemarie T. Brooks, Marjory B. |
author_sort | Cremer, Signe E. |
collection | PubMed |
description | Domestic dogs share the same environment as humans, and they represent a valuable animal model to study naturally-occurring human disease. Platelet proteomics holds promise for the discovery of biomarkers that capture the contribution of platelets to the pathophysiology of many disease states, however, canine platelet proteomic studies are lacking. Our study objectives were to establish a protocol for proteomic identification and quantification of the thrombin-activated canine platelet secretome (CAPS), and to compare the CAPS proteins to human and murine platelet proteomic data. Washed platelets were isolated from healthy dogs, and stimulated with saline (control) or gamma-thrombin (releasate). Proteins were separated by SDS-page, trypsin-digested and analyzed by liquid chromatography and tandem mass spectrometry (MS). CAPS proteins were defined as those with a MS1-abundance ratio of two or more for releasate vs. unstimulated saline control. A total of 1,918 proteins were identified, with 908 proteins common to all dogs and 693 characterized as CAPS proteins. CAPS proteins were similar to human and murine platelet secretomes and were highly represented in hemostatic pathways. Differences unique to CAPS included replacement of platelet factor 4 with other cleavage products of platelet basic protein (e.g. interleukin-8), novel proteins (e.g. C-C motif chemokine 14), and proteins in relatively high (e.g. protease nexin-1) or low (e.g. von Willebrand factor) abundance. This study establishes the first in-depth platelet releasate proteome from healthy dogs with a reference database of 693 CAPS proteins. Similarities between CAPS and the human secretome confirm the utility of dogs as translational models of human disease, but we also identify differences unique to canine platelets. Our findings provide a resource for further investigations into disease-related CAPS profiles, and for comparative pathway analyses of platelet activation among species. |
format | Online Article Text |
id | pubmed-6853320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-68533202019-11-22 Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) Cremer, Signe E. Catalfamo, James L. Goggs, Robert Seemann, Stefan E. Kristensen, Annemarie T. Brooks, Marjory B. PLoS One Research Article Domestic dogs share the same environment as humans, and they represent a valuable animal model to study naturally-occurring human disease. Platelet proteomics holds promise for the discovery of biomarkers that capture the contribution of platelets to the pathophysiology of many disease states, however, canine platelet proteomic studies are lacking. Our study objectives were to establish a protocol for proteomic identification and quantification of the thrombin-activated canine platelet secretome (CAPS), and to compare the CAPS proteins to human and murine platelet proteomic data. Washed platelets were isolated from healthy dogs, and stimulated with saline (control) or gamma-thrombin (releasate). Proteins were separated by SDS-page, trypsin-digested and analyzed by liquid chromatography and tandem mass spectrometry (MS). CAPS proteins were defined as those with a MS1-abundance ratio of two or more for releasate vs. unstimulated saline control. A total of 1,918 proteins were identified, with 908 proteins common to all dogs and 693 characterized as CAPS proteins. CAPS proteins were similar to human and murine platelet secretomes and were highly represented in hemostatic pathways. Differences unique to CAPS included replacement of platelet factor 4 with other cleavage products of platelet basic protein (e.g. interleukin-8), novel proteins (e.g. C-C motif chemokine 14), and proteins in relatively high (e.g. protease nexin-1) or low (e.g. von Willebrand factor) abundance. This study establishes the first in-depth platelet releasate proteome from healthy dogs with a reference database of 693 CAPS proteins. Similarities between CAPS and the human secretome confirm the utility of dogs as translational models of human disease, but we also identify differences unique to canine platelets. Our findings provide a resource for further investigations into disease-related CAPS profiles, and for comparative pathway analyses of platelet activation among species. Public Library of Science 2019-11-13 /pmc/articles/PMC6853320/ /pubmed/31721811 http://dx.doi.org/10.1371/journal.pone.0224891 Text en © 2019 Cremer et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Cremer, Signe E. Catalfamo, James L. Goggs, Robert Seemann, Stefan E. Kristensen, Annemarie T. Brooks, Marjory B. Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title | Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title_full | Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title_fullStr | Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title_full_unstemmed | Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title_short | Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS) |
title_sort | proteomic profiling of the thrombin-activated canine platelet secretome (caps) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853320/ https://www.ncbi.nlm.nih.gov/pubmed/31721811 http://dx.doi.org/10.1371/journal.pone.0224891 |
work_keys_str_mv | AT cremersignee proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps AT catalfamojamesl proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps AT goggsrobert proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps AT seemannstefane proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps AT kristensenannemariet proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps AT brooksmarjoryb proteomicprofilingofthethrombinactivatedcanineplateletsecretomecaps |